Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Sep 22, 2023 9:21am
142 Views
Post# 35648930

Things to look forward to & putting aside the price

Things to look forward to & putting aside the price collaring.  I'll be totally honest, yesterday I did not get disheartened in LABS one bit but I did get upset to see on an ongoing basis the manipulation in this equity.   I told myself that will get washed away with the proper news and profits flowing to the bottom line.   What items do we have to look forward to? 

1) Passage of the SAFER banking act next Wednesday
2) FDA drug monograph that we and LABS are waiting for...Q4
3) Mr. Pidduck showing us their 'plan to generate cash in the near term'...Q4
4) Brazil drug approval and LABS revealing the drug and partner in Brazil...Q4
5) LABS first profitable quarter in Q1, 2024

other opportunities....

6) News on the  NDA or New Drug Application 
7) DEA rescheduling from I to III
8) Per Mr. Pidduck...open to further M&A...either acquiring or being acquired(fully or partially)

I personally believe that the 'global pharmaceutical partner' that LABS is involved with is headquartered in the U.S. and so, whether I like it or not, SAFER and DEA rescheduling will be critical for LABS and their global pharma partner because LABS is in Canada and if my belief of their global pharma partner being headquartered in the U.S., you now have cross border flow of cannabinoid based API's as well as wire transfers for payments.  

So I've told myself, do NOT become focused on a stock price that is blatantly and purposely manipulated but to keep my focus on the bigger picture, like something from 60,000 feet as Pidduck suggested...good advice. 
<< Previous
Bullboard Posts
Next >>